JO
IPXL

John Overdeck’s Impax Laboratories, Inc. IPXL Stock Holding History

John Overdeck’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-254,905
Closed -$4.1M – 3430
2017
Q2 		$4.1M Sell
254,905
-382,744
-60% -$5.65M 0.01% 969
2017
Q1 		$8.07M Sell
637,649
-428,130
-40% -$5.17M 0.03% 712
2016
Q4 		$14.1M Buy
1,065,779
+1,031,863
+3,042% +$17.6M 0.05% 423
2016
Q3 		$804K Sell
33,916
-19,741
-37% -$531K ﹤0.01% 2127
2016
Q2 		$1.55M Sell
53,657
-24,067
-31% -$784K 0.01% 1439
2016
Q1 		$2.49M Sell
77,724
-162,346
-68% -$5.71M 0.01% 1061
2015
Q4 		$10.3M Buy
240,070
+212,641
+775% +$8.49M 0.05% 413
2015
Q3 		$966K Sell
27,429
-215,981
-89% -$9.73M ﹤0.01% 1223
2015
Q2 		$11.2M Buy
243,410
+236,473
+3,409% +$11.2M 0.05% 415
2015
Q1 		$325K Buy
+6,937
New +$276K ﹤0.01% 2223
2014
Q3 		– Sell
-19,216
Closed -$576K – 2238
2014
Q2 		$576K Sell
19,216
-275,205
-93% -$7.42M ﹤0.01% 1547
2014
Q1 		$7.78M Sell
294,421
-920
-0.3% -$23K 0.04% 506
2013
Q4 		$7.42M Buy
295,341
+121,651
+70% +$2.71M 0.04% 506
2013
Q3 		$3.56M Buy
+173,690
New +$3.59M 0.02% 611

Other funds holding IPXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

John Overdeck's IPXL Position: Q3 2017 in Review

John Overdeck sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 254,905 shares — an estimated $4.1M sold.

John Overdeck first reported a position in IPXL in Q3 2013 and held it in 14 quarters. The position peaked at $14.1M in Q4 2016. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • John Overdeck reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • John Overdeck sold 254,905 Impax Laboratories, Inc. shares in Q3 2017, an estimated $4.1M.
  • John Overdeck first reported a position in Impax Laboratories, Inc. in Q3 2013 and held it in 14 quarters.
  • John Overdeck's Impax Laboratories, Inc. position peaked at $14.1M in Q4 2016.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Two Sigma Investments's 13F filing for Q3 2017, filed 14 Nov 2017.